335 related articles for article (PubMed ID: 21156980)
1. The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation.
Mathew B; Lennon FE; Siegler J; Mirzapoiazova T; Mambetsariev N; Sammani S; Gerhold LM; LaRiviere PJ; Chen CT; Garcia JG; Salgia R; Moss J; Singleton PA
Anesth Analg; 2011 Mar; 112(3):558-67. PubMed ID: 21156980
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis.
Lennon FE; Mirzapoiazova T; Mambetsariev B; Salgia R; Moss J; Singleton PA
Anesthesiology; 2012 Apr; 116(4):857-67. PubMed ID: 22343475
[TBL] [Abstract][Full Text] [Related]
3. Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor.
Gorur A; Patiño M; Shi T; Corrales G; Takahashi H; Rangel R; Gleber-Netto FO; Pickering C; Myers JN; Cata JP
J Cell Physiol; 2021 Nov; 236(11):7698-7710. PubMed ID: 34038587
[TBL] [Abstract][Full Text] [Related]
4. The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer.
Lennon FE; Mirzapoiazova T; Mambetsariev B; Poroyko VA; Salgia R; Moss J; Singleton PA
PLoS One; 2014; 9(3):e91577. PubMed ID: 24662916
[TBL] [Abstract][Full Text] [Related]
5. Increased μ-opioid receptor expression in metastatic lung cancer.
Singleton PA; Mirzapoiazova T; Hasina R; Salgia R; Moss J
Br J Anaesth; 2014 Jul; 113 Suppl 1(Suppl 1):i103-8. PubMed ID: 24920011
[TBL] [Abstract][Full Text] [Related]
6. Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer.
Fujioka N; Nguyen J; Chen C; Li Y; Pasrija T; Niehans G; Johnson KN; Gupta V; Kratzke RA; Gupta K
Anesth Analg; 2011 Dec; 113(6):1353-64. PubMed ID: 22003224
[TBL] [Abstract][Full Text] [Related]
7. Mast cells and histamine enhance the proliferation of non-small cell lung cancer cells.
Stoyanov E; Uddin M; Mankuta D; Dubinett SM; Levi-Schaffer F
Lung Cancer; 2012 Jan; 75(1):38-44. PubMed ID: 21733595
[TBL] [Abstract][Full Text] [Related]
8. micro-Opioid receptor activation prevents acute hepatic inflammation and cell death.
Chakass D; Philippe D; Erdual E; Dharancy S; Malapel M; Dubuquoy C; Thuru X; Gay J; Gaveriaux-Ruff C; Dubus P; Mathurin P; Kieffer BL; Desreumaux P; Chamaillard M
Gut; 2007 Jul; 56(7):974-81. PubMed ID: 17299060
[TBL] [Abstract][Full Text] [Related]
9. Mu-opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1.
Connor M; Schuller A; Pintar JE; Christie MJ
Br J Pharmacol; 1999 Apr; 126(7):1553-8. PubMed ID: 10323586
[TBL] [Abstract][Full Text] [Related]
10. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
11. Mu-opioid receptor activation promotes in vitro and in vivo tumor growth in head and neck squamous cell carcinoma.
Gorur A; Patiño M; Takahashi H; Corrales G; Pickering CR; Gleber-Netto FO; Myers JN; Cata JP
Life Sci; 2021 Aug; 278():119541. PubMed ID: 33930368
[TBL] [Abstract][Full Text] [Related]
12. CB(2) cannabinoid receptor antagonist SR144528 decreases mu-opioid receptor expression and activation in mouse brainstem: role of CB(2) receptor in pain.
Páldy E; Bereczki E; Sántha M; Wenger T; Borsodi A; Zimmer A; Benyhe S
Neurochem Int; 2008 Dec; 53(6-8):309-16. PubMed ID: 18804501
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation.
Philippe D; Dubuquoy L; Groux H; Brun V; Chuoï-Mariot MT; Gaveriaux-Ruff C; Colombel JF; Kieffer BL; Desreumaux P
J Clin Invest; 2003 May; 111(9):1329-38. PubMed ID: 12727924
[TBL] [Abstract][Full Text] [Related]
14. Mu-opioid receptor and delta-opioid receptor differentially regulate microglial inflammatory response to control proopiomelanocortin neuronal apoptosis in the hypothalamus: effects of neonatal alcohol.
Shrivastava P; Cabrera MA; Chastain LG; Boyadjieva NI; Jabbar S; Franklin T; Sarkar DK
J Neuroinflammation; 2017 Apr; 14(1):83. PubMed ID: 28407740
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of the mu-opioid receptor at tyrosine 166 (Tyr3.51) in the DRY motif reduces agonist efficacy.
Clayton CC; Bruchas MR; Lee ML; Chavkin C
Mol Pharmacol; 2010 Mar; 77(3):339-47. PubMed ID: 19959593
[TBL] [Abstract][Full Text] [Related]
16. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins.
Melkes B; Hejnova L; Novotny J
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1289-1300. PubMed ID: 27600870
[TBL] [Abstract][Full Text] [Related]
17. Effect of perioperative opioids on cancer recurrence: a hypothesis.
Singleton PA; Moss J
Future Oncol; 2010 Aug; 6(8):1237-42. PubMed ID: 20799870
[TBL] [Abstract][Full Text] [Related]
18. CB1 receptor-independent actions of SR141716 on G-protein signaling: coapplication with the mu-opioid agonist Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol unmasks novel, pertussis toxin-insensitive opioid signaling in mu-opioid receptor-Chinese hamster ovary cells.
Cinar R; Szücs M
J Pharmacol Exp Ther; 2009 Aug; 330(2):567-74. PubMed ID: 19448142
[TBL] [Abstract][Full Text] [Related]
19. The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche.
Castañón E; Soltermann A; López I; Román M; Ecay M; Collantes M; Redrado M; Baraibar I; López-Picazo JM; Rolfo C; Vidal-Vanaclocha F; Raez L; Weder W; Calvo A; Gil-Bazo I
Cancer Lett; 2017 Aug; 402():43-51. PubMed ID: 28549790
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation.
Singleton PA; Moreno-Vinasco L; Sammani S; Wanderling SL; Moss J; Garcia JG
Am J Respir Cell Mol Biol; 2007 Aug; 37(2):222-31. PubMed ID: 17395891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]